Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Dual Therapy With Darunavir and Ritonavir Plus Lamivudine vs Triple Therapy With Darunavir and Ritonavir Plus Tenofovir Disoproxil Fumarate and Emtricitabine or Abacavir and Lamivudine for Maintenance of Human Immunodeficiency Virus Type 1 Viral Suppression: Randomized, Open-Label, Noninferiority DUAL-GESIDA 8014-RIS-EST45 Trial

PaperCitations, authors & open-access status

Dual Therapy With Darunavir and Ritonavir Plus Lamivudine vs Triple Therapy With Darunavir and Ritonavir Plus Tenofovir Disoproxil Fumarate and Emtricitabine or Abacavir and Lamivudine for Maintenance of Human Immunodeficiency Virus Type 1 Viral Suppression: Randomized, Open-Label, Noninferiority DUAL-GESIDA 8014-RIS-EST45 Trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 102 citations, 2017 year and green oa status.

102
Citations
2017
Year
green
OA Status

Related on ScholarIQ

Esperanza Merino
Author
HIV/AIDS drug development and treatment
Topic
HIV/AIDS drug development and treatment
Topic
HIV-related health complications and treatments
Topic
HIV Research and Treatment
Topic
470M+ articles · free account